Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Baricitinib was effective in treating both early and late onset alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Baricitinib is effective and safe for treating alopecia areata.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Ivermectin and sulfur effectively treated the cat's scabies and sporotrichosis in 14 days.

Baricitinib is effective and safe for treating severe alopecia areata.

Tocilizumab might be an effective treatment for COVID-19.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Antifungal treatment reduced asthma exacerbations and corticosteroid use but its overall benefit is unclear.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Tinea infections need proper diagnosis and treatment with topical or oral antifungals based on severity and location.